当前位置:首页 - 行情中心 - 康缘药业(600557) - 财务分析

康缘药业

(600557)

  

流通市值:76.36亿  总市值:76.80亿
流通股本:5.78亿   总股本:5.82亿

康缘药业(600557)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润3.64亿元,每股收益0.62元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益533574.36万元,未分配利润439267.82万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产690273.96万元,负债156699.60万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入3,109,535,857.512,259,796,227.61,359,020,285.934,867,806,702.4
营业总成本2,769,653,537.121,996,276,733.861,187,013,990.734,359,915,092.72
营业利润422,301,093.99312,511,123.63182,594,683.81563,792,393.22
利润总额427,258,722.9316,812,470.59177,601,538.14550,982,603.37
净利润363,983,299.76271,295,082.87149,567,584.88547,050,271.78
其他综合收益----
综合收益总额363,983,299.76271,295,082.87149,567,584.88547,050,271.78
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,730,071,208.273,900,536,632.874,222,203,715.694,049,719,426.38
非流动资产合计3,172,668,343.373,153,710,9663,157,767,457.513,067,602,241.14
资产总计6,902,739,551.647,054,247,598.877,379,971,173.27,117,321,667.52
流动负债合计1,436,151,924.031,560,306,769.41,714,116,520.031,608,688,119.36
非流动负债合计130,844,037.37158,433,825.2156,496,236.01128,080,808.28
负债合计1,566,995,961.41,718,740,594.61,870,612,756.041,736,768,927.64
归属于母公司股东权益合计5,150,151,026.085,148,521,172.35,326,721,847.475,192,797,030.75
股东权益合计5,335,743,590.245,335,507,004.275,509,358,417.165,380,552,739.88
负债和股东权益合计6,902,739,551.647,054,247,598.877,379,971,173.27,117,321,667.52
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计3,780,893,455.712,808,035,561.591,476,423,811.85,775,649,064.14
经营活动现金流出小计3,173,371,397.812,417,290,079.71,277,555,884.914,734,645,214.25
经营活动产生的现金流量净额607,522,057.9390,745,481.89198,867,926.891,041,003,849.89
投资活动现金流入小计1,586,271,488.851,277,105,834.12517,789,654.581,069,174,484.8
投资活动现金流出小计1,919,921,739.981,230,995,432.04623,276,787.321,609,480,998.28
投资活动产生的现金流量净额-333,650,251.1346,110,402.08-105,487,132.74-540,306,513.48
筹资活动现金流入小计---4,858,700
筹资活动现金流出小计429,395,392.37336,943,761.4516,479,528.36134,671,199.44
筹资活动产生的现金流量净额-429,395,392.37-336,943,761.45-16,479,528.36-129,812,499.44
汇率变动对现金及现金等价物的影响134,707.5119,245.62-61,773.6
现金及现金等价物净增加额-155,388,878.1100,031,368.1476,901,265.79370,946,610.57
期末现金及现金等价物余额1,816,857,563.462,072,277,809.72,046,174,149.111,972,246,441.56
TOP↑